DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS

NEW YORK and JERUSALEM, Jan. 6, 2022 /PRNewswire/ — Dr. Morris C. Laster (“Dr. Laster”), who, together with other proxy participants, beneficially owns 6,006,000 shares of common stock, par value $0.001, of Scopus BioPharma Inc. (Nasdaq: SCPS) (“Scopus” or the “Company”), announced today…